Li Bowen, Cui Hao, Liu Wei, Lan Zhou, Liu Chang, Yang Yumiao, Zhao Yuyue, Tian Zhen, Chen Hao, Yu Guangtao
Stomatological Hospital, School of Stomatology, Southern Medical University, Guangzhou, Guangdong 510280, China.
Research (Wash D C). 2025 May 9;8:0697. doi: 10.34133/research.0697. eCollection 2025.
DEAD-box ATPase 10 (DDX10), a prominent RNA-binding protein in the DDX family, has a critical function in cancer progression. Nevertheless, its well-defined mechanisms in oral squamous cell carcinoma (OSCC) are still not well understood. Here, we identify that DDX10 is substantially increased in OSCC, which is positively correlated with poor prognosis and malignant behavior. Mechanistically, we found that DDX10 had physical interaction with Rab27b by undergoing phase separation. Knockdown of DDX10 inhibited Rab27b-mediated exosome secretion and the expression of programmed cell death-ligand 1 (PD-L1) within its contents. Furthermore, knocking down DDX10 could restore the function and infiltration of T cells, hence inhibiting the progression of OSCC. These findings highlight that the oncogenic role of DDX10 in promoting exosomal PD-L1 secretion via phase separation with Rab27b has been preliminarily validated in T cell exhaustion in OSCC. A potential strategy for improving OSCC immunotherapy may involve the inhibition of DDX10.
DEAD盒ATP酶10(DDX10)是DDX家族中一种重要的RNA结合蛋白,在癌症进展中起关键作用。然而,其在口腔鳞状细胞癌(OSCC)中明确的作用机制仍未完全清楚。在此,我们发现DDX10在OSCC中显著上调,这与不良预后和恶性行为呈正相关。机制上,我们发现DDX10通过相分离与Rab27b发生物理相互作用。敲低DDX10可抑制Rab27b介导的外泌体分泌及其内容物中程序性细胞死亡配体1(PD-L1)的表达。此外,敲低DDX10可恢复T细胞的功能和浸润,从而抑制OSCC的进展。这些发现表明,DDX10通过与Rab27b相分离促进外泌体PD-L1分泌的致癌作用在OSCC的T细胞耗竭中已得到初步验证。改善OSCC免疫治疗的潜在策略可能包括抑制DDX10。